INNOVATION THAT MATTERS

Brave Science: Putting the ‘Hutzpah’ in Early-Stage Drug Discovery – A Chat with Ehud...

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) From developing new paradigms for early-stage drug discovery for rare and common diseases to fostering the convergence of peptide nanotechnology, and launching...

INDUSTRY BEATS

THE LAUNCHPAD

Game Changer: Scientist Mark Waller Ready to “Go” to Next level with AI-Driven Synthesis

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx)   Renowned chemist and computational scientist Mark Waller is ready to go to the next level with a new approach that employs...

Drug Makers Developing Non-Opioid Pain Alternatives to Battle the Opioid Epidemic

The biopharmaceutical industry, recognizing the role of prescription opioids in the epidemic of addiction gripping the US, has launched efforts to address the crisis by developing non-opioid alternatives for pain. However,...

Experienced Investment Analyst Predicts Non-Opioid Pain Drugs Will Reduce Opioid Abuse and Health Care...

Corey Davis, Ph.D., Managing Director of Equity Research at Seaport Global Securities, has more than 20 years of sell side experience covering just about every therapeutic area within the specialty pharma...

WUXI NEWS

WuXi AppTec Lab Testing Division’s Bioanalytical Service Unit Passed FDA Inspection

We are pleased to announce that WuXi’s  Lab Testing Division(LTD)’s Bioanalytical facility in Shanghai once again passed US FDA’s bioequivalence (BE) inspection with no 483 observations. The inspectors from FDA thoroughly audited...

WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

We are pleased to announce that WuXi Biologics  has received the 2017 Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC, a leading consulting firm. WuXi Biologics has been recognized for its outstanding performance for...

LabNetwork Integrates with Reaxys to Offer Seamless Experience from Chemistry Research to Purchase

We look forward to the new collaboration between LabNetwork, WuXi AppTec’s global chemistry ecommerce platform company, and Elsevier, a world-leading provider of scientific, technical and medical information products and services. Under the...

FDA DRUG APPOVALS / DESIGNATIONS

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Game Changer: Scientist Mark Waller Ready to “Go” to Next level...

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx)   Renowned chemist and computational scientist Mark Waller is ready to go to the next...